Intended Use

For the quantitative in vitro determination of Amylase in serum, plasma or urine. This product is suitable for automated, semi-automated and manual use.

Clinical Significance

The method uses ethylidene blocked p nitrophenyl maltoheptaoside as substrate. The indicator enzyme glucosidase, used to release the p nitrophenol, is also employed in the method. The terminal glucose of the substrate is chemically blocked preventing cleavage by the indicator enzymes.

Product Availability

Product availability may vary from country to country. Some products may be for research use only. For more information on product availability please contact marketing@randox.com